T. Annie T. Fong

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

T. Annie T. Fong, Laura K. Shawver, Li Sun et al. · PubMed · 1999 · 1K citations

Medicine, Oncology, Pharmacology +16

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Alexander Laird, Peter Vajkoczy, Laura K. Shawver et al. · PubMed · 2000 · 497 citations

Medicine, Medicinal Chemistry, Pharmacology +16

The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells

Amin Hajitou, Christine Grignet‐Debrus, Laetitia Devy et al. · The FASEB Journal · 2002 · 163 citations

Medicine, Oncology, Pharmacology +17

Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

Peter Vajkoczy, Michael D. Menger, Brigitte Vollmar et al. · Neoplasia · 1999 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis

Véronique Masson, Laetitia Devy, Christine Grignet‐Debrus et al. · Biological Procedures Online · 2002 · 140 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +9